Disappointing results of two human trials of monoclonal antibodies in Parkinson’s disease
Like Alzheimer’s disease, Parkinson’s disease is a progressive, neurodegenerative disorder that involves deposits of an abnormal protein in the brain. In Alzheimer’s disease, these abnormal proteins are extracellular beta-amyloid and intraneuronal hyperphosphorylated tau. In Parkinson’s...
Recent Comments